Temporomandibularibular disorders (TMDs) are complex conditions that necessitate a multidisciplinary approach in order to achieve effective therapy [17]. Recent advancements have introduced novel diagnostic and therapeutic modalities that enhance the understanding and treatment of TMDs. Digital occlusal analysis systems, for example, provide detailed insights into bite force distribution and temporomandibular joint (TMJ) function, allowing for more targeted and effective treatments. Telemedicine has become a crucial instrument for treating temporomandibular disorders (TMDs), especially in light of the COVID-19 pandemic [18]. Teleconsultations enable patients to access specialized assistance and continuous therapy without the necessity of in-person appointments. This is particularly advantageous for individuals with limited mobility or those residing in isolated regions. Digital platforms enable the exchange of diagnostic data, such as digital scans and radiography, which enable clinicians to remotely evaluate and track patients' ailments.  
Telemedicine is revolutionizing the management of TMDs and expanding access to dental care overall [19; 20]. By using telehealth platforms, dentists can conduct virtual consultations, provide real-time treatment recommendations, and monitor patients' progress remotely. This approach is particularly advantageous for managing chronic conditions, post-operative care, and follow-up appointments. Additionally, telemedicine supports patient education and engagement by providing platforms for interactive communication. Patients can receive personalized oral hygiene instructions, dietary advice, and educational resources that empower them to take an active role in their oral health care [21].  
The efficacy of elastodontic devices in managing TMDs has been a recent focus of research. A study by [PERSON] et al. compared the clinical efficacy of the Eptamed elastodontic device to a common bite sold in pharmacies, assessing surface electromyography (sEMG) and kinesography activities of masticatory and postural muscles before and after six months of treatment [22]. The Eptamed device was found to significantly improve the electrical activity in the examined muscles, promoting greater relaxation and reducing the risk of worsening TMD symptoms compared to a standard bite, which showed a general worsening of muscle activity [22]. These findings indicate that elastodontic devices have the capacity to be an effective and minimally invasive therapy option for temporomandibular disorders (TMDs) as they assist in maintaining a proper equilibrium of the nerves and muscles involved, hence improving outcomes for patients.  
The integration of digitalization, cutting-edge technologies, and telemedicine in dentistry and the treatment of craniofacial/TMD diseases is introducing a new period characterized by accuracy, effectiveness, and patient-focused healthcare. These innovations not only enhance diagnostic accuracy and treatment outcomes but also improve accessibility and convenience for patients. As these technologies evolve, their adoption is set to become more widespread, fundamentally transforming dental and craniofacial healthcare. The future of this field relies on the ongoing adoption of these cutting-edge innovations, ensuring patients receive the highest standard of care. Implementing these enhancements will lead to improved medical results, heightened patient contentment, and a more efficient healthcare system.  
The authors declare no conflicts of interest.